Although heart failure due to a wide variety of pathological stimuli including myocardial
infarction, pressure overload and volume overload is associated with cardiac hypertrophy …

Anticoagulants are used to prevent clot formation both in vitro and in vivo. In the specific field
of in vitro diagnostics, anticoagulants are commonly added to collection tubes either to …

Background B-type natriuretic peptide is released from the cardiac ventricles in response to
increased wall tension. Methods We conducted a prospective study of 1586 patients who …

Background—Although Doppler echocardiography has been used to identify abnormal left
ventricular (LV) diastolic filling dynamics, inherent limitations suggest the need for additional …

OBJECTIVES The goal of this study was to evaluate the utility of a rapid “bedside” technique
for measurement of B-type natriuretic peptide (BNP) in the diagnosis of congestive heart …

OBJECTIVES The goal of this study was to determine if B-type natriuretic peptide (BNP)
levels predict outcomes of patients admitted with decompensated heart failure …

Objectives: This study examines B-type natriuretic peptide (BNP) levels in patients with
systolic versus non-systolic dysfunction presenting with shortness of breath. Background …

Abstract Background Galectin-3 (Gal-3) is a recently discovered marker for myocardial
fibrosis and elevated levels are associated with an impaired outcome after short-term follow …

Background Although echocardiography is an important tool for making the diagnosis of left
ventricular (LV) dysfunction, the cost of this procedure limits its use as a routine screening …

In patients with heart failure, plasma levels of atrial natriuretic peptide (ANP), B-type
natriuretic peptide (BNP), and the N-terminal fragments of their prohormones (N-ANP and N …